Postoperative synthetic human atrial natriuretic peptide infusion and oral spironolactone administration for a patient with giant atria and low plasma level of atrial natriuretic peptide
Hayashi, Y.; Ohtani, M.; Hiraishi, T.; Kobayashi, Y.
Journal of Thoracic and Cardiovascular Surgery 124(1): 206-209
2002
ISSN/ISBN: 0022-5223 PMID: 12091838 DOI: 10.1067/mtc.2002.122683
Accession: 047025890
Full Text Article emailed within 0-6 h: $19.90
Related References
Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; Macgregor, G.A. 1994: N-Terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma Investigation of plasma levels and molecular circulating form using radioimmunoassays for pro-atrial natriuretic peptide , pro-atrial natriuretic peptide and atrial natriuretic peptide Clinical Science 87(3): 311-317Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; Macgregor, G.A. 1994: N-terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma : investigation of plasma levels and molecular circulating form(s) using radioimmunoassays for pro-atrial natriuretic peptide (31-67), pro-atrial natriuretic peptide (1-30) and atrial natriuretic peptide (99-126) Clinical Science (1979) 87(3): 311-317
Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; MacGregor, G.A. 1994: N-terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma: investigation of plasma levels and molecular circulating form(s) using radioimmunoassays for pro-atrial natriuretic peptide (31-67), pro-atrial natriuretic peptide (1-30) and atrial natriuretic peptide (99-126) Clinical Science 87(3): 311-317
Hayashi, Y.; Ohtani, M.; Sawa, Y.; Hiraishi, T.; Kobayashi, Y.; Matsuda, H. 2004: Left atrial diameter is a simple indicator of a deficiency in atrial natriuretic peptide secretion in patients with mitral stenosis: efficacy of postoperative supplementation with synthetic human alpha-atrial natriuretic peptide Journal of Cardiovascular Pharmacology 44(6): 709-717
Pohl, U.; Schuon, J.; Weidemann, H.; Bassenge, E. 1990: Increased plasma level of atrial natriuretic peptide in patients with stress-induced coronary insufficiency: stretch-independent release of atrial natriuretic peptide? Zeitschrift für Kardiologie 79(3): 193-198
Hiroe, M.; Naruse, M.; Aonuma, K.; Nagata, M.; Ohta, Y.; Taniguchi, K.; Sekiguchi, M. 1988: Effects of atrial pacing tachycardia on the ultrastructural changes in biopsied right atria and the contents of human atrial natriuretic peptide in the atria and plasma European Heart Journal 9(ABSTR Suppl 1): 72
Buckley, M.G.; Sagnella, G.A.; Markandu, N.D.; Singer, D.R.J.; MacGregor, G.A. 1989: Immunoreactive N -terminal Pro-Atrial Natriuretic Peptide in Human Plasma: Plasma Levels and Comparisons with -Human Atrial Natriuretic Peptide in Normal Subjects, Patients with Essential Hypertension, Cardiac Transplant and Chronic Renal Failure Clinical Science 77(5): 573-579
Bucklay, M.G.; Sagnella, G.A.; Markandu, N.D.; Singer, D.R.J.; Macgregor, G.A. 1989: Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with α-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure Clinical Science (1979) 77(5): 573-579
Buckley, M.G.; Sagnella, G.A.; Markandu, N.D.; Singer, D.R.; MacGregor, G.A. 1989: Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with alpha-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure Clinical Science 77(5): 573-579
Boomsma, F.; Bhaggoe, U.M.; Man in 't Veld, A.J.; Schalekamp, M.A. 1996: Comparison of N-terminal pro-atrial natriuretic peptide and atrial natriuretic peptide in human plasma as measured with commercially available radioimmunoassay kits Clinica Chimica Acta; International Journal of Clinical Chemistry 252(1): 41-49
Bruckley, M.G.; Sagnella, G.A.; Markandu, N.D.; Singer, D.R.J.; Macgregor, G.A. 1989: Immunoreactive amino terminal pro atrial natriuretic peptide in human plasma plasma levels and comparisons with alpha human atrial natriuretic peptide in normal subjects patients with essential hypertension cardiac transplant and chronic renal failure Clinical Science 77(5): 573-579
Lamprecht, J.; Plum, J. 1990: Plasma level of atrial natriuretic peptide following oral glycerol administration Laryngo- Rhino- Otologie 69(1): 31-34
Omland, T.; Aakvaag, A.; Bonarjee, V.V.S.; Caidahl, K.; Lie, R.T.; Nilsen, D.W.T.; Sundsfjord, J.A.; Dickstein, K. 1996: Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction : Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93(11): 1963-1969
Omland, T.; Aakvaag, A.; Bonarjee, V.V.; Caidahl, K.; Lie, R.T.; Nilsen, D.W.; Sundsfjord, J.A.; Dickstein, K. 1996: Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93(11): 1963-1969
Schiebinger, R.J.; Baker, M.Z.; Linden, J. 1987: Effect of adrenergic and muscarinic cholinergic agonists on atrial natriuretic peptide secretion by isolated rat atria: potential role of the autonomic nerbous system in modulating atrial natriuretic peptide secretion The Journal of Clinical Investigation 80(6): 1687-1691
Schiebinger, R.J.; Baker, M.Z.; Linden, J. 1987: Effect of adrenergic and muscarinic cholinergic agonists on atrial natriuretic peptide secretion by isolated rat atria. Potential role of the autonomic nervous system in modulating atrial natriuretic peptide secretion Journal of Clinical Investigation 80(6): 1687-1691
Nishikimi, T.; Mori, Y.; Ishimura, K.; Tadokoro, K.; Yagi, H.; Yabe, A.; Horinaka, S.; Matsuoka, H. 2004: Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function American Journal of Medicine 116(8): 517-523
Legault, L.; Warner, L.C.; Wai Ming, L.E.U.N.G.; Logan, A.G.; Blendis, L.M.; Skorecki, K.L. 1993: Assessment of atrial natriuretic peptide resistance in cirrhosis with lead-out water immersion and atrial natriuretic peptide infusion Canadian Physiological Society. Winter Meeting 71(2): 157-164
Legault, L.; Warner, L.C.; Leung, W.M.; Logan, A.G.; Blendis, L.M.; Skorecki, K.L. 1993: Assessment of atrial natriuretic peptide resistance in cirrhosis with head-out water immersion and atrial natriuretic peptide infusion Canadian Journal of Physiology and Pharmacology 71(2): 157-164
Tamura, N.; Ogawa, Y.; Yasoda, A.; Itoh, H.; Saito, Y.; Nakao, K. 1996: Two cardiac natriuretic peptide genes (atrial natriuretic peptide and brain natriuretic peptide) are organized in tandem in the mouse and human genomes Journal of Molecular and Cellular Cardiology 28(8): 1811-1815